CareFusion Names Kieran T. Gallahue Chairman and CEO
SAN DIEGO, Feb. 1, 2011 /PRNewswire/ -- CareFusion  Corporation (NYSE: CFN ), a global, medical technology company, announced today the appointment of Kieran T. Gallahue as chairman and chief executive officer, succeeding David L. Schlotterbeck who previously announced plans to retire later this month.
A seasoned medical-technology executive, Mr. Gallahue, 47, was most recently president and CEO of ResMed (NYSE: RMD ), a global leader in medical equipment for treating, diagnosing and managing sleep-related respiratory disorders.
During his tenure, the company grew revenue approximately 500 percent to $1.2 billion, while expanding operating margins and increasing net income more than 20 percent annually. He built an exceptional management team and global organization that commercialized products in more than 70 countries.
Mr. Gallahue has nearly 20 years of strategic, operational and corporate management experience in the health care industry, with deep expertise in the medical technologies field. Since 2007, he has also served on the board of Volcano Corp., a developer of products for interventional cardiology.
"Kieran brings strategic, operational and public company experience to CareFusion, with a proven track record of growth – all qualities that were critical in our search process," said J. Michael Losh, presiding director of the CareFusion board. "CareFusion has ample opportunities to grow and innovate, as we execute against our near-term plans to expand margins. We see a clear path to create exponentially greater value and believe Kieran is an ideal fit to accelerate this work."
Mr. Gallahue said, "It is a rare opportunity to join a company with an end-to-end portfolio of category leading products yet with such growth